The AHRQ Safety Program for Methicillin-Resistant Staphylococcus aureus (MRSA) Prevention
Revision of a currently approved collection
No
Regular
Approved without change
11/22/2022
10/19/2022
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
11/30/2025
36 Months From Approved
08/31/2024
36,928
0
36,637
12,052
0
11,552
0
0
0
The Agency for Healthcare Research and Quality (AHRQ) requests to revise the currently approved AHRQ Safety Program for Methicillin-Resistant Staphylococcus aureus (MRSA) Prevention. The AHRQ Safety Program for MRSA Preventionâs purpose is to reduce the incidence and prevalence of infections caused by MRSA in a variety of settings. The revision for the AHRQ Safety Program for MRSA Prevention includes the following modifications:
1. ICU/Non-ICU cohort: The optional point prevalence data will be collected at baseline (pre-intervention) and every six months throughout the 18-month implementation period rather than only at baseline.
2. Surgical Services cohort: After a discussion with the programâs Technical Expert Panel (TEP), it was decided to collect surgical site infection (SSI) outcome data on a different subset of surgical procedures performed within the cardiac surgery, orthopedic surgery, and neurosurgery specialty areas.
3. Long-Term Care (LTC) cohort: The LTC cohort will now also submit the Minimum Data Set (MDS) 3.0 M Skin Conditions data elements.
US Code:
42 USC 299
Name of Law: Agency for Healthcare Research and Quality Act of 1999
There is a reduction in burden from 15 minutes to 12.5 minutes per survey for the HSOPS 2.0 due to the shorter length of the instrument compared to Version 1.0.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.